Governance, monitoring, and surveillance systems are crucial to verify safety and efficacy throughout a product’s lifecycle. This is especially true for artificial intelligence applications which are highly data-dependent.

Our CEO, Kanwal Bhatia, joins Tessa Cook, Associate Professor of Radiology at the Perelman School of Medicine at the University of Pennsylvania, and Hortense Allison, VP and Head of Regulatory Medical Devices and Digital at Bayer, review the current state of post-marketing surveillance for AI software designed for use in healthcare, discuss the regulatory gaps from a developer and end user’s perspective, and offer expert opinions on improvements and changes to be made in the future.

https://www.auntminnie.com/resources/webinars/video/15683772/bayer-healthcare-postmarket-surveillance-for-ai-applications